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CASE REPORT
Toxicology
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Abstract
Pulmonary ultrasound is a useful tool in the diagnosis and resuscitation of emergency
department (ED) patients with dyspnea. We present the case of a patient who was
diagnosed with E-cigarette or vaping product use-associated lung injury (EVALI) using
pulmonary ultrasound. Many of these cases are diagnosed using x-ray, computerized
tomography, or bronchoscopy and to our knowledge this is the first published case
that demonstrates utility of ultrasound in diagnosing EVALI. While more investigation
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is needed on the use of this technique, the patient in this case was diagnosed with
EVALI based on positive history, presence of normal cardiac function, non-cardiogenic
pulmonary edema on ultrasound, and absence of pulmonary infection.

INTRODUCTION

are no published reports of pulmonary ultrasound use in diagnosing
EVALI.4,5

E-cigarette use, or vaping, is increasingly prevalent as a modality for
tobacco and tetrahydrocannabinol (THC) consumption. The long-term
effects of electronic cigarette use are not yet known due to its rel-
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CASE

ative infancy, but E-cigarette or vaping product use-associated lung
injury (EVALI) has become a recognized condition. EVALI is a spectrum

A previously healthy 26-year-old male with a medical history of

of disease that includes diffuse alveolar hemorrhage, lipoid pneumo-

exercise-induced asthma and e-cigarette use presented with dysp-

nia, acute eosinophilic pneumonia, hypersensitivity pneumonitis, and

nea and cough for 9 days. The patient presented to the hospital in

organizing

pneumonia.1,2

Patients may present to the hospital with

November of 2019, before the Covid-19 pandemic. He was evaluated

a myriad of symptoms that can include dyspnea, cough, chest pain,

at an urgent care where he was diagnosed with pneumonia and

exercise intolerance, gastrointestinal upset and interventions required

placed on doxycycline. He remained symptomatic and was seen in

may range from simple monitoring to supplemental oxygen admin-

an outside hospital ED where azithromycin was added. Two days

istration, mechanical ventilation, extracorporeal membrane oxygena-

prior to presentation to our ED he was again seen at urgent care and

transplant.3

Due to the diverse nature of complaints,

given albuterol/ipratroprium nebulizer treatments, an intramuscular

the differential diagnosis in these cases is broad and includes pneu-

dose of dexamethasone, and levofloxacin. One day prior to arrival he

monia, bronchitis, pulmonary edema secondary to cardiac or noncar-

developed blood-tinged sputum. His last use of e-cigarettes containing

diac causes, obstructive lung disease, pulmonary embolism, and acute

THC was 5 days prior to arrival, though he reported over 1 year of

coronary syndrome. Diagnosis is made by clinical history and imaging

using THC-containing canisters.

tion, and lung

suggestive of lung injury. Imaging with chest x-ray and computerized

On presentation to our ED, the patient was found to be hypox-

tomography (CT) scan can show ground glass opacities indicative of

emic to 88% on room air and tachypneic. He was placed on 2L O2 by

lung injury and bronchoscopy can aid in diagnosis but to date there

nasal cannula with some improvement in symptoms and vital signs.
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FIGURE 1

Ultrasound of right lung apex demonstrates diffuse B lines indicating pulmonary edema

Pulmonary exam revealed diffuse rales with mild expiratory wheezes.
The differential diagnosis in this otherwise healthy patient with new
onset dyspnea, cough, and oxygen requirement included pneumonia,
bronchitis, asthma exacerbation, pneumothorax, pulmonary embolism,
heart failure, and cardiogenic pulmonary edema. Given the patient’s
history of e-cigarette use, EVALI was also considered.
Point-of-care ultrasound of the lungs and transthoracic echocardiogram were performed to evaluate the patient’s disease process. Bedside echocardiogram consisting of the standard subxiphoid, parasternal long and short, IVC, and apical 4 chamber views showed a grossly
normal left ventricular ejection fraction (LVEF), no right heart strain,
and no pericardial effusion. Ultrasound of the lungs was performed
using the bedside lung ultrasound in emergency protocol and 6 views
were obtained.6 Views of the inferior and superior anterior lungs
and mid-thoracic posterior axillary line were obtained for a total of 6
images and diffuse B lines were visualized throughout all lung fields
(Figure 1). The presence of multiple B lines, or discrete hyperechoic
reverberation artifacts emanating from the pleural line and extending
into the lung parenchyma, indicated interstitial fluid.7 The patient had
appropriate lung sliding bilaterally, indicating the absence of a pneumothorax. The posterior axillary line views showed no pleural effusion.

FIGURE 2

CT scan of chest showing diffuse alveolar hemorrhage

There was no evidence of pneumonia as the patient had no visualized
consolidations or air bronchograms and there was no hepatization of
the lungs.8 The presence of diffuse B-lines in conjunction with a normal

weaned off supplemental oxygen. On discharge, the patient was able

LVEF led to the diagnosis of diffuse noncardiogenic pulmonary edema.

to ambulate without oxygen while maintaining a normal oxygen sat-

The patient’s history of using THC-containing vape cartridges and evi-

uration. He was found to be negative for streptococcus pneumoniae,

dence of lung injury on imaging were consistent with EVALI. A CT scan

legionella, influenza, RSV, HIV, hepatitis, and mycoplasma. A compre-

of the patient’s lungs confirmed the diagnosis (Figure 2).

hensive respiratory viral panel was also negative. Sputum and blood

The patient’s condition improved over the course of his hospitalization. He received steroids and nebulizer treatments and was eventually

cultures were negative. A CT scan the day of discharge showed resolution of his lung injury.
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DISCUSSION

aid in the evaluation of dyspneic ED patients, and this case highlights its
utility in diagnosing this emerging disease. More research is needed to

Pulmonary edema, most likely secondary to diffuse alveolar hemor-

determine its sensitivity in diagnosing EVALI and whether ultrasound

rhage, is a known complication of e-cigarette use. While there is no con-

findings correlate with symptom severity or disease progression.

sensus on a single cause of EVALI, the presence of vitamin E acetate
in THC oil-containing samples has been linked to lung injury.9 Surfactant disruption by hydrophobic vitamin E likely results in lung injury,
causing non cardiogenic pulmonary edema. Despite having significant
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lung injury and vital sign abnormalities, these patients often have normal exams by pulmonary auscultation. In this patient, use of ultrasound
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tion, effusion, or pneumothorax.
Importantly, this patient had previously been diagnosed with pneumonia after chest x-rays at an urgent care and outside hospital. While
his symptoms of cough and dyspnea in the presence of an abnormal chest x-ray were concerning for pneumonia, the patient did not
improve with antibiotics and fortunately continued to seek medical
care. Point-of-care lung ultrasound ultimately proved more valuable
in diagnosing his condition. The presence of B-lines on the patient’s
bedside ultrasound with appropriate lung sliding and lack of air bronchograms or hepatization indicated pulmonary edema rather than
pneumonia as the most likely diagnosis. As stated previously, the
absence of anechoic pleural effusions in the inferior thorax and the
presence of appropriate lung sliding excluded other potential causes of
the patient’s symptoms.
While EVALI represents a spectrum of disease, this patient’s particular injury resulted in the development of interstitial fluid and pulmonary edema that was visible by ultrasound. Point-of-care ultrasound
is well recognized as a useful modality in dyspneic patients, and in
this patient with hypoxemia pneumothorax, effusion, consolidation,
and cardiogenic causes were quickly excluded. While auscultation and
chest x-ray can diagnose pulmonary edema, they alone are not sufficient to determine its cause. Ultrasound was useful in diagnosing pulmonary edema in this patient by demonstrating diffuse B lines without
evidence of other potential causes to the patient’s dyspnea. A point-ofcare echocardiogram showed normal ejection fraction, which indicated
a non-cardiogenic cause to this patient’s pulmonary edema. Ultrasound
findings identified the patient’s pathology and taken with a history
of E-cigarette use, the diagnosis of EVALI was confirmed. The patient
was therefore treated with steroids rather than diuretics or antibiotics
according to the current treatment recommendations for EVALI.10
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CONCLUSION

E-cigarette or vaping product use-associated lung injury
(EVALI) characterized by pulmonary ultrasound. JACEP Open.

EVALI represents a spectrum of disease with a broad range of symptom
severity. Pulmonary ultrasound is widely recognized as an important
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